Atlas Trials

Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses

Clinical trial NCT03752307 · COMPLETED

Trial details

NCT number
NCT03752307
Sponsor
University of New Mexico
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2019-02-15
Primary completion
2023-07-06
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.